An Analysis of Antimicrobial Technologies in Dental Practices to Advance Safety and Efficacy During a Pandemic

Presented by Dr. Herb Moskowitz, Chairman, ioTech International
September 24, 2020: 5 - 6 p.m. PDT
Herb Moskowitz ioTech headshot

Dr. Herb Moskowitz, DDS

Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech's U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.


An Analysis of Antimicrobial Technologies in Dental Practices to Advance Safety and Efficacy

During a Pandemic


1 CEU: Live Interactive Webinar

COST: No Charge

AGD PACE Subject Code: 010 Basic Sciences. Pharmacotherapeutics, Emerging Technologies

SPONSOR: ioTech International

PRESENTER: Dr. Herb Moskowitz


A new generation of super-iodines is being developed with proven anti-virucidal activity against SARS-CoV-2. This course will analyze the efficacy and safety of current anti-microbial rinses and introduce the latest generation of rinses under development. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses to protect both patients and staff.

HINT: If you are currently using hydrogen peroxide or chlorhexidine gluconate as a pre-procedural rinse, you will be surprised by the results of these studies.


  1. Review the evolution of iodine in becoming a standard of care.

  2. Learn about a technological breakthrough leading to a new class of “super” iodines​.

  3. Understand how the implementation of the new “super” iodines in your practice will benefit your patients.

  4. Compare the advantages and disadvantages of commonly used oral rinses.

  5. Describe the misconceptions related to iodine sensitivity.

  6. Learn why periodontal bacteremias are now considered a cause of cardiovascular disease.


The views expressed and opinions and materials presented during these presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speakers' own clinical experience and should not be construed as Dental CE Academy recommended. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in the fields of dentistry. Dental CE Academy appreciates its members who share their knowledge. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding.

According to Dental CE Academy's  Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.


Dr. Moskowitz is the Chairman of ioTech International. Dr. Moskowitz is financially affiliated with ioTech International and is a paid speaker. Dental CE Academy has no financial interest or association with ioTech International or any of the companies other than hosting services.